Physician profile
Hing Chung Lee
NPI 1740248335
$3,681.12
in general payments reported to CMS, 2019-2025
38 companies · $594 in 2025
The $594 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,154 · 2020: $474 · 2022: $92.08 · 2023: $609 · 2024: $757 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,960.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $638.61 | 2019-2025 | Vemlidy, Livdelzi |
| Pfizer INC. | $366.45 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $337.00 | 2019-2025 | Lokelma, Breztri, Airsupra |
| Novo Nordisk INC | $259.84 | 2019-2024 | Wegovy, Saxenda |
| Merck Sharp & Dohme LLC | $245.29 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Daiichi Sankyo INC. | $175.98 | 2019-2020 | |
| Amgen INC. | $157.85 | 2019-2025 | Evenity, Otezla, Repatha |
| Glaxosmithkline, LLC. | $135.86 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $135.09 | 2019-2024 | |
| Shield Therapeutics INC | $114.87 | 2024 | |
| Sanofi-Aventis U.S. LLC | $100.26 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $100.00 | 2025 | Neffy |
| Amarin Pharma, INC. | $99.66 | 2019-2023 | |
| Lilly USA, LLC | $85.78 | 2019-2023 | Mounjaro |
| Exact Sciences Corporation | $85.25 | 2024 | Cologuard Collection Kit |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hing Chung Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.